BindingDB PrimarySearch

Found 2 hits Enz. Inhib. hit(s) with Target = 'Nuclear receptor ROR-gamma [262-507]' and Ligand = 'BDBM382950'
Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	k_off s^-1	k_on M^-1s^-1	pH	Temp °C
Nuclear receptor ROR-gamma [262-507] (Homo sapiens (Human))	BDBM382950 (US10273259, Example 661 \| US10273259, Example 663 ...) Show SMILES Show InChI	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	10	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The binding of potential ligands to RORγ is measured by competition with [3H]25-hydroxycholesterol (Perkin Elmer NET674250UC) using a scintillat...				US Patent US10711020 (2020) BindingDB Entry DOI: 10.7270/Q2N019JS
Bristol-Myers Squibb Company US Patent					More data for this Ligand-Target Pair
Nuclear receptor ROR-gamma [262-507] (Homo sapiens (Human))	BDBM382950 (US10273259, Example 661 \| US10273259, Example 663 ...) Show SMILES Show InChI	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.61E+3	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The binding of potential ligands to RORγ is measured by competition with [3H]25-hydroxycholesterol (Perkin Elmer NET674250UC) using a scintillat...				US Patent US10711020 (2020) BindingDB Entry DOI: 10.7270/Q2N019JS
Bristol-Myers Squibb Company US Patent					More data for this Ligand-Target Pair